Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method to identify subjects at higher risk to develop an autoimmune disease based on genetic and/or phenotypic screening for epistatic variants in DDX39B (RS2523506) and IL7R (RS6897932)

Method to identify subjects at higher risk to develop an autoimmune disease based on genetic and/or phenotypic screening for epistatic variants in DDX39B (RS2523506) and IL7R (RS6897932)

US Patent 10961581 · Granted Mar 30, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune di2025
Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune di2025
Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune di2025
Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune di2025
Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune di2025
Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune di2025
Method to identify subjects at higher risk to develop an autoimmune disease base2025
Method to identify subjects at higher risk to develop an autoimmune disease base2025
Method to identify subjects at higher risk to develop an autoimmune disease base2025
Method to identify subjects at higher risk to develop an autoimmune disease base2025
Method to identify subjects at higher risk to develop an autoimmune disease base2025
Method to identify subjects at higher risk to develop an autoimmune disease base2025